Do you want to know more on the HCPs behaviour changes during COVID-19 lockdown? Let Fonny Schenck (CEO, Across Health) walk you through the findings of our most recent Navigator Spotcheck (302 oncologists in EU5 + US).
Some of the key questions of our second COVID-related webinar:
- Which channels shifted most in terms of reach, impact and
frequency vs Q4 2019?
- What kind of pharma content are HCPs looking for online?
- Are there key differences between geo markets – and between
HCP segments?
- How do oncologists see the future role of the rep?
- Which companies are “best-in-class”?
We trust this session will help you reimagine the future of customer engagement in biopharma!
For the recorded webinar and the full deck please visit:
https://bit.ly/3ewb0zX
Navigating the multichannel maze in COVID-19 times – key tactics: pitfalls an...Across Health
As COVID-19 is spreading rapidly across the world, the traditional HCP customer engagement model in life sciences has come to a grinding halt.
This webinar -presented by Fonny Schenck (CEO, Across Health), Patrick Vidal (Managing Partner, Across Health) and Vanessa Huichard (Senior Consultant, Across Health)- will help you navigate the multichannel maze in COVID-19 days.
Besides unique insights, pragmatic recommendations, and robust cases, this session includes hot-off-the-press research results from our Navigator Spotcheck (with the views of 300 EU5 Specialists and GPs, on what they want from pharma in these times of social distancing) and our Maturometer Snapshot (featuring the views of 100+ pharma staff on their very-short term priorities in this period – and the longer view).
For the recorded webinar please visit:
https://bit.ly/2wFNqjS
2019-2020: Blip or shift? Key trends in the HCP mixAcross Health
Using relevant insights from our Navigator365 platform, Fonny Schenck (CEO) and David Ziedman (Head of Accounts) will take you back to 2020, explore key shifts vs 2019, and lift a tip of the veil on the Omnichannel Customer Engagement market dynamics you can expect in 2021 and beyond.
Key topics include:
• HCP shifts in channel & content affinity & impact
• HCP interest in & (dis)satisfaction with biopharma’s digital offerings
• Emerging competitor moves
• Future scenarios
Watch the recorded webinar on our website: http://bit.ly/3kUVNNi.
Across Health Multichannel Maturometer 2019Across Health
Across Health is pleased to present you with the state of the multichannel landscape in life sciences – now in its 11th year.
After 3 years of robust growth in digital marketing budgets, 2019 showed a pullback to 2017 levels. We have a couple of hypotheses to explain this surprising finding:
1. Hesitation to invest more in the absence of a clear view on ROI and strategic priorities/roadmap;
2. More participants who are just getting started on their digital journey;
3. A smarter use of digital dollars (“more bang for the buck”);
4. We have reached the end stage of digital transformation in life sciences
Across Health firmly believes that the main driver for smaller budgets is option 1.
You can find out why in the report.
In this session, Fonny Schenck (EVP PV&H, MD Across Health) and Pim ten Tusscher (Chief Technology Officer) are lifting the veil on some recent and upcoming advanced uses of Navigator365™, the industry’s leading ecosystem for actionable omnichannel insights, planning, execution and impact tracking.
Key topics include:
• How to “go beyond averages” and compare & contrast subsegments of customers (age, gender, archetype, (sub)specialty,…) -- with just one click!
• A sneak peek into some of the new features & functionalities:
- advanced benchmarking
- advanced time trends
- Payer Navigator365™
- Navigator365™Planner and
- Tracker integration
Watch the recorded webinar and access the full deck on our website: https://bit.ly/3EzgeZo
C19: Respond, recover & reimagine the future of HCP engagementAcross Health
And Across Health responded in an agile way to the C19 disruption: we've taken important steps in optimizing the Navigator ecosystem, with over 6,000 HCP respondents since June, insightful COVID-19 questions, new Powertools, upgrades to our integrated OCE Planner Pro, the launch of a DIY “starterkit”, a new OCE capability-boosting platform (SCALA), etc.
Our webinar will take you through the latest Navigator 365 insights, demo the newest Powertools, and show how the data can be used for evidence-based omnichannel HCP journey planning, orchestration, measurement - and ongoing optimization.
Watch the recorded webinar on our website: https://bit.ly/2UmkvcU.
Webinar - Multichannel Maturometer 2018 results: Key global trendsAcross Health
Questions answered include:
• Did the 20%+ budget increase in 2017 continue in 2018?
• Which channels have reached maturity…and which ones could break out in the next years?
• What are the industry's biggest bottlenecks for adopting digital?
• (How) are key digital capabilities developing versus last year?
• How satisfied is the industry with its digital efforts to date?
For the recorded webinar please visit our website: http://bit.ly/2vC86oc
Across Health Multichannel Maturometer 2020Across Health
In many industries, COVID-19 has accelerated the move to digital transformation. As Microsoft’s CEO, Satya Nadella, put it: “We saw 2 years of digital transformation in 2 months.”
Is biopharma moving at the speed of light too? The Maturometer research gives you a unique overview of what others are planning/doing in this space, including topics like:
- Organizational dimension - burning platform (or not)?
- Key investment focus – which channels, technologies, staff capabilities?
- Budget levels for digital
- Key barriers
- Key priorities for 2021
- …
Access the full deck and watch the recording: https://bit.ly/3l3kWFa
Excelling in omnichannel engagement: how-to & industry reference casesAcross Health
“I hear and I forget. I see and I remember. I do and I understand”
Within the spirit of Confucius, we aim at helping you remember and understand the key ingredients of the omnichannel engagement recipe. This webinar will take you one step further on your journey.
This webinar intends to:
• Show you how implementing deep customer insights and agile mix techniques can help create impactful and engaging marketing plans
• Bring to life the integration process using examples and case studies
For the recorded webinar please visit: http://bit.ly/2mmqh0i
Navigating the multichannel maze in COVID-19 times – key tactics: pitfalls an...Across Health
As COVID-19 is spreading rapidly across the world, the traditional HCP customer engagement model in life sciences has come to a grinding halt.
This webinar -presented by Fonny Schenck (CEO, Across Health), Patrick Vidal (Managing Partner, Across Health) and Vanessa Huichard (Senior Consultant, Across Health)- will help you navigate the multichannel maze in COVID-19 days.
Besides unique insights, pragmatic recommendations, and robust cases, this session includes hot-off-the-press research results from our Navigator Spotcheck (with the views of 300 EU5 Specialists and GPs, on what they want from pharma in these times of social distancing) and our Maturometer Snapshot (featuring the views of 100+ pharma staff on their very-short term priorities in this period – and the longer view).
For the recorded webinar please visit:
https://bit.ly/2wFNqjS
2019-2020: Blip or shift? Key trends in the HCP mixAcross Health
Using relevant insights from our Navigator365 platform, Fonny Schenck (CEO) and David Ziedman (Head of Accounts) will take you back to 2020, explore key shifts vs 2019, and lift a tip of the veil on the Omnichannel Customer Engagement market dynamics you can expect in 2021 and beyond.
Key topics include:
• HCP shifts in channel & content affinity & impact
• HCP interest in & (dis)satisfaction with biopharma’s digital offerings
• Emerging competitor moves
• Future scenarios
Watch the recorded webinar on our website: http://bit.ly/3kUVNNi.
Across Health Multichannel Maturometer 2019Across Health
Across Health is pleased to present you with the state of the multichannel landscape in life sciences – now in its 11th year.
After 3 years of robust growth in digital marketing budgets, 2019 showed a pullback to 2017 levels. We have a couple of hypotheses to explain this surprising finding:
1. Hesitation to invest more in the absence of a clear view on ROI and strategic priorities/roadmap;
2. More participants who are just getting started on their digital journey;
3. A smarter use of digital dollars (“more bang for the buck”);
4. We have reached the end stage of digital transformation in life sciences
Across Health firmly believes that the main driver for smaller budgets is option 1.
You can find out why in the report.
In this session, Fonny Schenck (EVP PV&H, MD Across Health) and Pim ten Tusscher (Chief Technology Officer) are lifting the veil on some recent and upcoming advanced uses of Navigator365™, the industry’s leading ecosystem for actionable omnichannel insights, planning, execution and impact tracking.
Key topics include:
• How to “go beyond averages” and compare & contrast subsegments of customers (age, gender, archetype, (sub)specialty,…) -- with just one click!
• A sneak peek into some of the new features & functionalities:
- advanced benchmarking
- advanced time trends
- Payer Navigator365™
- Navigator365™Planner and
- Tracker integration
Watch the recorded webinar and access the full deck on our website: https://bit.ly/3EzgeZo
C19: Respond, recover & reimagine the future of HCP engagementAcross Health
And Across Health responded in an agile way to the C19 disruption: we've taken important steps in optimizing the Navigator ecosystem, with over 6,000 HCP respondents since June, insightful COVID-19 questions, new Powertools, upgrades to our integrated OCE Planner Pro, the launch of a DIY “starterkit”, a new OCE capability-boosting platform (SCALA), etc.
Our webinar will take you through the latest Navigator 365 insights, demo the newest Powertools, and show how the data can be used for evidence-based omnichannel HCP journey planning, orchestration, measurement - and ongoing optimization.
Watch the recorded webinar on our website: https://bit.ly/2UmkvcU.
Webinar - Multichannel Maturometer 2018 results: Key global trendsAcross Health
Questions answered include:
• Did the 20%+ budget increase in 2017 continue in 2018?
• Which channels have reached maturity…and which ones could break out in the next years?
• What are the industry's biggest bottlenecks for adopting digital?
• (How) are key digital capabilities developing versus last year?
• How satisfied is the industry with its digital efforts to date?
For the recorded webinar please visit our website: http://bit.ly/2vC86oc
Across Health Multichannel Maturometer 2020Across Health
In many industries, COVID-19 has accelerated the move to digital transformation. As Microsoft’s CEO, Satya Nadella, put it: “We saw 2 years of digital transformation in 2 months.”
Is biopharma moving at the speed of light too? The Maturometer research gives you a unique overview of what others are planning/doing in this space, including topics like:
- Organizational dimension - burning platform (or not)?
- Key investment focus – which channels, technologies, staff capabilities?
- Budget levels for digital
- Key barriers
- Key priorities for 2021
- …
Access the full deck and watch the recording: https://bit.ly/3l3kWFa
Excelling in omnichannel engagement: how-to & industry reference casesAcross Health
“I hear and I forget. I see and I remember. I do and I understand”
Within the spirit of Confucius, we aim at helping you remember and understand the key ingredients of the omnichannel engagement recipe. This webinar will take you one step further on your journey.
This webinar intends to:
• Show you how implementing deep customer insights and agile mix techniques can help create impactful and engaging marketing plans
• Bring to life the integration process using examples and case studies
For the recorded webinar please visit: http://bit.ly/2mmqh0i
Across Health Multichannel Maturometer 2017Across Health
Across Health is pleased to present you with the state of the
multichannel landscape in life sciences in Europe, US and
emerging markets – now in its ninth year.
This year we took a wider view at where digital dollars are going – particularly at patient engagement and digital innovation. Results show that global and local have different views on their effectiveness and importance…
Also, while we see budgets and teams growing (after five years!), satisfaction remains (incredibly) low.
To learn more please watch the recorded version of our webinar: https://goo.gl/Q275oq
The power of marketing & sales collaboration for omnichannel engagementAcross Health
Reimagine the role of customer-facing teams, guided by Beverly Smet (SVP Global Accounts) and Christoph Schmidt (Head of Strategy).
The major takeaways of this webinar include:
• The new commercial model in biopharma: a cross-functional, customer-centric ecosystem
• Roadmap to data-driven omnichannel customer engagement vs the current reality in biopharma
• Case study with demonstrated impact on omnichannel engagement through marketing & sales collaboration
• Key steps for omnichannel engagement success
Watch the recorded webinar and access the full deck on our website: https://bit.ly/2PBTOST
Given the time and expense required to bring a prescription drug to market, coupled with its limited exclusive lifespan and an increasing complex and competitive healthcare environment, companies must maximize every moment during the critical launch window. And digital is increasingly seen as a key contributor to success…but is this truly the case?
Watch the recording of the second Maturometer Snapshot webinar and discover it yourself: http://bit.ly/35BOYY1.
Omnichannel upskilling: transforming customer-oriented teams into omnichannel...Across Health
Across Health senior consultants Jean-Sebastien Struyf and Luisa Schirm illustrate the role of Scala365™ and blended learning as a key component of digital transformation at scale within biopharma.
Key topics of this webinar include:
• What type of omnichannel competencies are needed for customer-oriented teams in a post-C19 world - and where is biopharma today?
• “It’s all in the mix” … also for learning styles and formats. How to create a winning learning journey featuring self-paced, blended and hands-on learning - for all key functions?
• How to boost not only knowledge and capabilities, but also change the mindset.
Watch the recorded webinar and access the full deck on our website: https://bit.ly/2RzF0Vu.
How to help HCPs swim in an ever faster eMedical education currentAcross Health
In recent years there has been a dramatic shift in the medical education needs and preferences of HCPs. This shift is accelerating and Pharma is in real danger of being left behind. This presentation will help you to get a clearer picture of the evolution of the HCP landscape. Should you want more information on this important topic, please read our blog https://goo.gl/QQSVwJ
Across Health Multichannel Maturometer 2018Across Health
Across Health is pleased to present you with the state of the multichannel landscape in life sciences in Europe, US and emerging markets – now in its tenth year. Results show that digitally trained staff numbers are still at historically low levels, and the same goes for other key enablers for digital transformation. Also, while we see budgets keep on growing, satisfaction remains low.
The journey towards digital natives: is pharma driving against the traffic?Across Health
The pharmaceutical industry’s customer base is moving in one definite direction: towards a ubiquity of digital-native HCPs. The implications of this should not be underestimated. As the information needs and preferences of medical professionals shift, pharma must adapt their communications to match if they’re to drive improvements in clinical care.
Find out how new segmentation models can help understand the best way to communicate with physicians: https://goo.gl/crvgv6
Food for thought: is pharma feeding HCPs the wrong diet?Across Health
Pharma is generating ever more content, ranging from descriptions about products to patient stories, to webinars, to emails…. But all this is irrelevant if the right physicians don’t see it at the right time.
The gap between what HCPs want and what HCPs get – the digital divide – is only growing.
More on the Digital Divide topic here: https://goo.gl/EHEc5Z
Pharma’s journey towards the multichannel repAcross Health
The multichannel rep is one of the most important near term tactics for most pharma execs… but how is it faring? Join us for the next instalment of our 1000 to 1 series – to see whether the reality of the multichannel rep is within reach for pharma today: https://goo.gl/qrYTDa
2 years in 2 months? Digital acceleration in biopharmaAcross Health
Relive Across Health first iD.cast: 90 minutes of inspiration on digital acceleration in biopharma
Get food and facts for thought on how biopharma companies can embrace the COVID-19 wake-up call and turn these disruptive times into an opportunity for hyper-acceleration and re-invention. The session featured two highly engaging speakers – and scored an NPS of 65!
- Peter Hinssen, Co-founder Nexxworks, serial entrepreneur, best-selling author, and thought leader on digitalization & innovation
The "VACINE" for the Never Normal and the hourglass model for corporate innovation
- Fonny Schenck, CEO Across Health
2 years in 2 months? Digital acceleration in biopharma
Watch the recorded webinar or download the slides to learn how to be the Phoenix in the biopharma world and create a sustainable competitive superiority: https://bit.ly/2IZDDLv.
The multichannel rep: slideware or sizzling? Key trends in EU5Across Health
Multichannel reps are a much discussed topic – but how many HCPs in Europe are actually being reached this way? Using the Across Health Navigator dataset, we are now able to see clearer than ever before that as hype has swelled, not everyone has heard the message…. Find out more in our new blog here https://goo.gl/ra7CZG.
Multichannel Maturometer Snapshot: Digital Transformation webinarAcross Health
Across Health has run the Multichannel Maturometer for a decade – and has tracked the importance of digital in the life science’s commercial mix, and are recognised as an industry-leading barometer of how things are changing.
But these changes are happening ever faster.
To keep up with one of the most dynamic areas of one of the most innovative industries in the world – we had to up the tempo. We’ve launched the snapshot – to take the temperature of the industry more often.
In this first Maturometer Snapshot we zoom in on the key components and bottlenecks of a digital transformation and how these are shifting throughout the lifecycle of a transformation programme.
Christoph Schmidt, Jan Keuppens and Sander Geysen will share the highlights of the 2021 Maturometer survey, which will give you a unique overview of what other life sciences companies are planning and doing in the omnichannel space.
Key topics include:
• Organisational dimension – what’s the sense of urgency? What’s people’s take on the companywide OCE strategy?
• Key investment focus – which channels, technologies, staff capabilities?
• Budget levels for the digital component of the omnichannel mix
• Key barriers
• Key priorities
Watch the recorded webinar and access the full deck on our website: https://bit.ly/3hdARRk
Measuring ROI in life sciences? Not a black & white storyAcross Health
The first results of the 2021 Maturometer confirm that the ROI question is more important than ever. Join Jan Keuppens (SVP Global Accounts) and Christophe Brock (Head of Intelligent Execution & Impact) to learn the value of a solid impact measurement approach: it not only influences key decision-making, but it also contributes to a change of mindset.
Key topics include:
• Why strong impact measurement relies on a strong strategy and business case development
o Impact measurement as key component of campaign and customer journey strategy
• How your omnichannel maturity influences the type & level of KPIs
o Realistic vs “vanity” KPIs
• Understand the continuum between “essential” and “state-of-the-art” KPIs
• Explore examples of how impact measurement influences key decision-making
Watch the recorded webinar and access the full deck on our website: https://bit.ly/3felUMK
Across Health Multichannel Maturometer 2015Across Health
To view the recorded webinar please visit: http://bit.ly/1cLENV1
We are pleased to present you with the 7th Across Health survey on multichannel in life sciences, previously known as the Barometer.
We renamed it to the Maturometer, to reflect the content more aptly. Indeed, we have revamped and simplified the Barometer, by clustering all questions around 4 key dimensions of digital maturity: strategy & organization, business processes & technology, multichannel integration and measurement. We trust this will give you a structured view and will provide you with actionable input to take your company to the next level.
Generally speaking, the 2015 results are in line with 2014 – with historically low satisfaction levels and the 4th consecutive year of plateauing budgets (at a low level). US and Europe are most pessimistic; emerging markets appear to be more positive overall – but that may be due to their relatively new entry into this space.
We do see however a difference in speed in the market – around 14% is implementing multichannel very quickly, is spending significantly more than the average, and feels comfortable with impact measurement etc…multichannel @ multispeed!
We trust that these early leaders will soon be followed by the early majority…my guess is that 2015 REALLY is the end of the beginning!
Fonny Schenck
CEO, Across Health
Across Health Multichannel Maturometer 2016Across Health
We are pleased to present you with the 8th Across Health Multichannel Maturometer in Life Sciences, which covers the 4 key dimensions of digital maturity: strategy & organization, business processes & technology, multichannel integration and measurement.
If you only look at the averages, the 2016 results are very much a copy-paste of the previous years. At 13%, average satisfaction levels remain at all-time-low levels, while average digital marketing budgets (15.7%) are status-quo for the 4th year running. Skill levels continue to be low, key channels are very similar, etc etc.
However, if you look beyond these averages, some early leaders can be identified. Indeed, 15% states that digital transformation is happening fast. In other words, while most of the eggs in the hatchery are still closed, some “chickens” have already hatched.
We saw the same trend in 2015, where the top 10% is outperforming the average company significantly (http://bit.ly/29qk2lg), except for key “pain points” like mix optimization, campaign management and KPIs.
And if you look at the 2015-2016 comparison (p26), you can again infer that there is some activity in the other eggs too…Indeed, customer databases are increasingly crosschannel, while the pain related to execution (mix planning and campaign management platforms) – and the lack of training - are felt much harder than in 2015…in other words, the other eggs could hatch soon…and MCM will never be the same again!
Happy reading & holidays!
Fonny
For the fifth year running, Across Health is presenting you with its truly unique digital landscape overview among life sciences in Europe, US and emerging markets. The Digital Barometer gives you a 360°view on the status, challenges and future of “The New Normal”, i.e. where digital has become a commodity & is fully integrated in the overall channel mix.
The hare and the tortoise of digital transformation in pharmaAcross Health
What is necessary for pharma’s digital transformation to accelerate? Vladimir Rogiers thinks through the key enablers for a fast moving digitization process in our latest 1000to1 blog https://goo.gl/2RD7ao
Across Health Multichannel Barometer 2014Across Health
Across Health 2014 Multichannel Barometer survey shows Pharma’s painful progress towards digital productivity.
The 2014 Multichannel Barometer survey from Across Health paints a picture of a Life Sciences industry still struggling to come to terms with the realities of multichannel marketing.
The survey, now in its sixth year, shows digital spend plateauing compared with 2013 (15.6% vs 16% of total marketing budgets). This is in stark contrast to other industries, where spending on multichannel initiatives is already well over 20% and set to increase by 10% in 2014.
As governments and organizations continue to work toward containing COVID-19 and stem the growing humanitarian toll it is exacting, the economic effects are also beginning to be felt. Through a series of regular, global surveys, we are tracking how customers’ expectations, spending, and behaviors are changing throughout the crisis across multiple countries over time. Please check back regularly for updates.
Canada Clinical Diagnostics Market Sample Report 2022 to 2030Insights10
Canada's clinical diagnostics is expected to witness significant growth from $3.9 Bn in 2022 to $4.9 Bn in 2030 with a CAGR of 3.1% for the year 2022-30.
Across Health Multichannel Maturometer 2017Across Health
Across Health is pleased to present you with the state of the
multichannel landscape in life sciences in Europe, US and
emerging markets – now in its ninth year.
This year we took a wider view at where digital dollars are going – particularly at patient engagement and digital innovation. Results show that global and local have different views on their effectiveness and importance…
Also, while we see budgets and teams growing (after five years!), satisfaction remains (incredibly) low.
To learn more please watch the recorded version of our webinar: https://goo.gl/Q275oq
The power of marketing & sales collaboration for omnichannel engagementAcross Health
Reimagine the role of customer-facing teams, guided by Beverly Smet (SVP Global Accounts) and Christoph Schmidt (Head of Strategy).
The major takeaways of this webinar include:
• The new commercial model in biopharma: a cross-functional, customer-centric ecosystem
• Roadmap to data-driven omnichannel customer engagement vs the current reality in biopharma
• Case study with demonstrated impact on omnichannel engagement through marketing & sales collaboration
• Key steps for omnichannel engagement success
Watch the recorded webinar and access the full deck on our website: https://bit.ly/2PBTOST
Given the time and expense required to bring a prescription drug to market, coupled with its limited exclusive lifespan and an increasing complex and competitive healthcare environment, companies must maximize every moment during the critical launch window. And digital is increasingly seen as a key contributor to success…but is this truly the case?
Watch the recording of the second Maturometer Snapshot webinar and discover it yourself: http://bit.ly/35BOYY1.
Omnichannel upskilling: transforming customer-oriented teams into omnichannel...Across Health
Across Health senior consultants Jean-Sebastien Struyf and Luisa Schirm illustrate the role of Scala365™ and blended learning as a key component of digital transformation at scale within biopharma.
Key topics of this webinar include:
• What type of omnichannel competencies are needed for customer-oriented teams in a post-C19 world - and where is biopharma today?
• “It’s all in the mix” … also for learning styles and formats. How to create a winning learning journey featuring self-paced, blended and hands-on learning - for all key functions?
• How to boost not only knowledge and capabilities, but also change the mindset.
Watch the recorded webinar and access the full deck on our website: https://bit.ly/2RzF0Vu.
How to help HCPs swim in an ever faster eMedical education currentAcross Health
In recent years there has been a dramatic shift in the medical education needs and preferences of HCPs. This shift is accelerating and Pharma is in real danger of being left behind. This presentation will help you to get a clearer picture of the evolution of the HCP landscape. Should you want more information on this important topic, please read our blog https://goo.gl/QQSVwJ
Across Health Multichannel Maturometer 2018Across Health
Across Health is pleased to present you with the state of the multichannel landscape in life sciences in Europe, US and emerging markets – now in its tenth year. Results show that digitally trained staff numbers are still at historically low levels, and the same goes for other key enablers for digital transformation. Also, while we see budgets keep on growing, satisfaction remains low.
The journey towards digital natives: is pharma driving against the traffic?Across Health
The pharmaceutical industry’s customer base is moving in one definite direction: towards a ubiquity of digital-native HCPs. The implications of this should not be underestimated. As the information needs and preferences of medical professionals shift, pharma must adapt their communications to match if they’re to drive improvements in clinical care.
Find out how new segmentation models can help understand the best way to communicate with physicians: https://goo.gl/crvgv6
Food for thought: is pharma feeding HCPs the wrong diet?Across Health
Pharma is generating ever more content, ranging from descriptions about products to patient stories, to webinars, to emails…. But all this is irrelevant if the right physicians don’t see it at the right time.
The gap between what HCPs want and what HCPs get – the digital divide – is only growing.
More on the Digital Divide topic here: https://goo.gl/EHEc5Z
Pharma’s journey towards the multichannel repAcross Health
The multichannel rep is one of the most important near term tactics for most pharma execs… but how is it faring? Join us for the next instalment of our 1000 to 1 series – to see whether the reality of the multichannel rep is within reach for pharma today: https://goo.gl/qrYTDa
2 years in 2 months? Digital acceleration in biopharmaAcross Health
Relive Across Health first iD.cast: 90 minutes of inspiration on digital acceleration in biopharma
Get food and facts for thought on how biopharma companies can embrace the COVID-19 wake-up call and turn these disruptive times into an opportunity for hyper-acceleration and re-invention. The session featured two highly engaging speakers – and scored an NPS of 65!
- Peter Hinssen, Co-founder Nexxworks, serial entrepreneur, best-selling author, and thought leader on digitalization & innovation
The "VACINE" for the Never Normal and the hourglass model for corporate innovation
- Fonny Schenck, CEO Across Health
2 years in 2 months? Digital acceleration in biopharma
Watch the recorded webinar or download the slides to learn how to be the Phoenix in the biopharma world and create a sustainable competitive superiority: https://bit.ly/2IZDDLv.
The multichannel rep: slideware or sizzling? Key trends in EU5Across Health
Multichannel reps are a much discussed topic – but how many HCPs in Europe are actually being reached this way? Using the Across Health Navigator dataset, we are now able to see clearer than ever before that as hype has swelled, not everyone has heard the message…. Find out more in our new blog here https://goo.gl/ra7CZG.
Multichannel Maturometer Snapshot: Digital Transformation webinarAcross Health
Across Health has run the Multichannel Maturometer for a decade – and has tracked the importance of digital in the life science’s commercial mix, and are recognised as an industry-leading barometer of how things are changing.
But these changes are happening ever faster.
To keep up with one of the most dynamic areas of one of the most innovative industries in the world – we had to up the tempo. We’ve launched the snapshot – to take the temperature of the industry more often.
In this first Maturometer Snapshot we zoom in on the key components and bottlenecks of a digital transformation and how these are shifting throughout the lifecycle of a transformation programme.
Christoph Schmidt, Jan Keuppens and Sander Geysen will share the highlights of the 2021 Maturometer survey, which will give you a unique overview of what other life sciences companies are planning and doing in the omnichannel space.
Key topics include:
• Organisational dimension – what’s the sense of urgency? What’s people’s take on the companywide OCE strategy?
• Key investment focus – which channels, technologies, staff capabilities?
• Budget levels for the digital component of the omnichannel mix
• Key barriers
• Key priorities
Watch the recorded webinar and access the full deck on our website: https://bit.ly/3hdARRk
Measuring ROI in life sciences? Not a black & white storyAcross Health
The first results of the 2021 Maturometer confirm that the ROI question is more important than ever. Join Jan Keuppens (SVP Global Accounts) and Christophe Brock (Head of Intelligent Execution & Impact) to learn the value of a solid impact measurement approach: it not only influences key decision-making, but it also contributes to a change of mindset.
Key topics include:
• Why strong impact measurement relies on a strong strategy and business case development
o Impact measurement as key component of campaign and customer journey strategy
• How your omnichannel maturity influences the type & level of KPIs
o Realistic vs “vanity” KPIs
• Understand the continuum between “essential” and “state-of-the-art” KPIs
• Explore examples of how impact measurement influences key decision-making
Watch the recorded webinar and access the full deck on our website: https://bit.ly/3felUMK
Across Health Multichannel Maturometer 2015Across Health
To view the recorded webinar please visit: http://bit.ly/1cLENV1
We are pleased to present you with the 7th Across Health survey on multichannel in life sciences, previously known as the Barometer.
We renamed it to the Maturometer, to reflect the content more aptly. Indeed, we have revamped and simplified the Barometer, by clustering all questions around 4 key dimensions of digital maturity: strategy & organization, business processes & technology, multichannel integration and measurement. We trust this will give you a structured view and will provide you with actionable input to take your company to the next level.
Generally speaking, the 2015 results are in line with 2014 – with historically low satisfaction levels and the 4th consecutive year of plateauing budgets (at a low level). US and Europe are most pessimistic; emerging markets appear to be more positive overall – but that may be due to their relatively new entry into this space.
We do see however a difference in speed in the market – around 14% is implementing multichannel very quickly, is spending significantly more than the average, and feels comfortable with impact measurement etc…multichannel @ multispeed!
We trust that these early leaders will soon be followed by the early majority…my guess is that 2015 REALLY is the end of the beginning!
Fonny Schenck
CEO, Across Health
Across Health Multichannel Maturometer 2016Across Health
We are pleased to present you with the 8th Across Health Multichannel Maturometer in Life Sciences, which covers the 4 key dimensions of digital maturity: strategy & organization, business processes & technology, multichannel integration and measurement.
If you only look at the averages, the 2016 results are very much a copy-paste of the previous years. At 13%, average satisfaction levels remain at all-time-low levels, while average digital marketing budgets (15.7%) are status-quo for the 4th year running. Skill levels continue to be low, key channels are very similar, etc etc.
However, if you look beyond these averages, some early leaders can be identified. Indeed, 15% states that digital transformation is happening fast. In other words, while most of the eggs in the hatchery are still closed, some “chickens” have already hatched.
We saw the same trend in 2015, where the top 10% is outperforming the average company significantly (http://bit.ly/29qk2lg), except for key “pain points” like mix optimization, campaign management and KPIs.
And if you look at the 2015-2016 comparison (p26), you can again infer that there is some activity in the other eggs too…Indeed, customer databases are increasingly crosschannel, while the pain related to execution (mix planning and campaign management platforms) – and the lack of training - are felt much harder than in 2015…in other words, the other eggs could hatch soon…and MCM will never be the same again!
Happy reading & holidays!
Fonny
For the fifth year running, Across Health is presenting you with its truly unique digital landscape overview among life sciences in Europe, US and emerging markets. The Digital Barometer gives you a 360°view on the status, challenges and future of “The New Normal”, i.e. where digital has become a commodity & is fully integrated in the overall channel mix.
The hare and the tortoise of digital transformation in pharmaAcross Health
What is necessary for pharma’s digital transformation to accelerate? Vladimir Rogiers thinks through the key enablers for a fast moving digitization process in our latest 1000to1 blog https://goo.gl/2RD7ao
Across Health Multichannel Barometer 2014Across Health
Across Health 2014 Multichannel Barometer survey shows Pharma’s painful progress towards digital productivity.
The 2014 Multichannel Barometer survey from Across Health paints a picture of a Life Sciences industry still struggling to come to terms with the realities of multichannel marketing.
The survey, now in its sixth year, shows digital spend plateauing compared with 2013 (15.6% vs 16% of total marketing budgets). This is in stark contrast to other industries, where spending on multichannel initiatives is already well over 20% and set to increase by 10% in 2014.
As governments and organizations continue to work toward containing COVID-19 and stem the growing humanitarian toll it is exacting, the economic effects are also beginning to be felt. Through a series of regular, global surveys, we are tracking how customers’ expectations, spending, and behaviors are changing throughout the crisis across multiple countries over time. Please check back regularly for updates.
Canada Clinical Diagnostics Market Sample Report 2022 to 2030Insights10
Canada's clinical diagnostics is expected to witness significant growth from $3.9 Bn in 2022 to $4.9 Bn in 2030 with a CAGR of 3.1% for the year 2022-30.
Canada's clinical diagnostics is expected to witness significant growth from $3.9 Bn in 2022 to $4.9 Bn in 2030 with a CAGR of 3.1% for the year 2022-30. The main growth drivers of the Canadian clinical diagnostics market are growing awareness about early disease detection and the benefits of early treatment. Further, the increasing investments by the government in diagnostic services are responsible for the market growth.To get a detailed report, contact us at - info@insights10.com
Patient Engagement Solutions Market by Product Type, Distribution Channel, En...IMARC Group
The global patient engagement solutions market size reached US$ 35.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 132.2 Billion by 2032, exhibiting a growth rate (CAGR) of 15.2% during 2024-2032.
More Info:- https://www.imarcgroup.com/patient-engagement-solutions-market
A Trust-Centric Healthcare Journey | Full Presentation of PharmaLedger's 1st ...PharmaLedger
In this #1 Open Webinar | A trust-centric healthcare journey presentation, you will find:
An introduction to the PharmaLedger project presented by Lynn Wang (Johnson & Johnson)
Topic 1 | Clinical Supply Traceability presented by Francesco Spoto (Novartis) and Chad Sklodosky (Pfizer)
Topic 2 | Finished Goods Traceability presented by Dr Jan Wortmann (Bayer) and Bernhard Salb (Roche)
Topic 3 | ePI – Electronic Product Information presented by Patrick Maher (Novartis) and Ken Thursby (MSD)
Topic 4 | Anti-Counterfeiting presented by Daniel Fritz (Novartis) and Alberto Lòpez (Imprensa Nacional Casa da Moeda)
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.
COVID-19 Data and Analytics: Survey Reveals Long- and Short-Term Healthcare I...Health Catalyst
Was COVID-19 a wake-up call to prioritize healthcare analytics and merge them with other healthcare goals? Healthcare data and analytics have become inextricable from the pandemic response, proving to the industry it can’t save lives at scale without this information and insight. In a 2021 survey of healthcare leaders and professionals, nearly 80 percent of respondents report they plan to maintain pandemic-driven data and analytics shifts for the long term. And with most respondents recognizing gaps in their data and analytics and noting COVID-19-driven changes in the data and analytics landscape, the pandemic may likely catalyze a new, more robust era in healthcare technology and decision support.
Pediatric Vaccines Market Growth, Demand and Challenges of the Key Industry P...IMARC Group
The global pediatric vaccines market size reached US$ 37.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 70.3 Billion by 2032, exhibiting a growth rate (CAGR) of 7.26% during 2024-2032.
More Info:- https://www.imarcgroup.com/pediatric-vaccines-market
Future Pharma Trends - Long-term opportunities tempered by short-term challengesscottosur
An overview of the key trends shaping the pharmaceutical industry today, and those that are set to play a central role in the future, as companies transition towards a new business model: Pharma 2.0.
Provides key strategies and trends shaping the future of the pharmaceutical industry. Examines the impact of the Obama administration on US healthcare, and the implications for Pharma. Assesses the implications of the current economic and financial situation on healthcare. Analyzes key growth drivers and resistors set to shape Pharma\'s future.
Contact me at sosur@datamonitor.com to learn more!
The global vaccine delivery devices market size reached US$ 7.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2028, exhibiting a growth rate (CAGR) of 7.5% during 2023-2028.
More info:- https://www.imarcgroup.com/vaccine-delivery-devices-market
Geopolitical Events| Vaccines Distribution| Canada and the World| May 1, 2021paul young cpa, cga
Blog – COVID19 – Pandemic Management – WE May 1, 2021
1. GDP / USA - https://www.bloomberg.com/news/articles/2021-04-29/u-s-economic-recovery-gained-steam-in-first-quarter-on-spending
2. Stranded capital - https://www2.deloitte.com/us/en/insights/economy/spotlight/economics-insights-analysis.html
3. USA fiscal management - https://www.slideshare.net/paulyoungcga/fiscal-management-federal-state-and-local-government-the-united-states It is interesting that USA is looking at policy changes when it comes to environment and not imposing a federal carbon tax on households and businesses. You would think @JustinTrudeau would look at all angles, right? Circular https://www.slideshare.net/paulyoungcga/how-best-to-managed-the-circular-economy
4. Supply Chain - https://www.supplychainbrain.com/articles/31024-coronavirus-watch-governments-rush-to-secure-ventilators
5. 3rd wave - https://www.fitchsolutions.com/topic/coronavirus
6. Geopolitical risks - https://globalriskinsights.com/
7. Climate Change - https://www.japantimes.co.jp/opinion/2021/04/29/commentary/world-commentary/cop26-carbon-emissions-climate-change-environment-u-s-china-russia/
8. Biden and Foreign Policies - https://www.theglobeandmail.com/world/article-will-bidens-pitting-of-democracies-against-autocracies-lead-to-a/
9. China Debt - https://www.bloomberg.com/opinion/articles/2021-04-28/how-ratings-agencies-ignored-china-debt-risks-over-huarong
10. Global Outlook https://www2.deloitte.com/us/en/insights/economy/global-economic-outlook/weekly-update.html
Therapeutic Vaccines Market Growth, Demand and Challenges of the Key Industry...IMARC Group
The global therapeutic vaccines market size reached US$ 31.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 71.4 Billion by 2032, exhibiting a growth rate (CAGR) of 9.5% during 2024-2032.
More Info:- https://www.imarcgroup.com/therapeutic-vaccines-market
Cholera Vaccines Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and ...IMARC Group
The global cholera vaccines market size reached US$ 5.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.0 Million by 2032, exhibiting a growth rate (CAGR) of 10% during 2024-2032.
More Info:- https://www.imarcgroup.com/cholera-vaccines-market
mHealth Israel_PwC Top Health Industry Issues of 2020Levi Shapiro
Review of 2020's top healthcare issues, by Ben Isgur, Head, PwC Health Research Institute:
1) A looming tsunami of high prices
2) Regulations trumps policy
3) Consumers inch closer to DIY healthcare
4) A whole new you- deals as makeovers
5) Equity and inclusion, not just diversity, as a business imperative
6) US health organizations are seeking opportunities overseas and through innovation. Beware of the tax risks
7) Fast- forwarding from data to decisions
Corporate Wellness Market by Product Type, Distribution Channel, End User 202...IMARC Group
The global corporate wellness market size reached US$ 66.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 118.6 Billion by 2032, exhibiting a growth rate (CAGR) of 6.5% during 2024-2032.
More Info:- https://www.imarcgroup.com/corporate-wellness-market
The global 3D bioprinting market is expected to grow, owing to its revolutionary breakthrough in healthcare and pharmaceutical industries. The increasing technological advancements, government intervention for improving healthcare, and increasing investments in R&D are also significant factors driving the studied market growth.
Companion Diagnostics Market PPT: Growth, Outlook, Demand, Keyplayer Analysis...IMARC Group
The global companion diagnostics market size reached US$ 5.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 11.7 Billion by 2027, exhibiting a growth rate (CAGR) of 14.78% during 2022-2027.
More Info:- https://www.imarcgroup.com/companion-diagnostics-market
Similar to Reimagine the future of customer engagement: second Navigator Spotcheck update (20)
Across Health - Key HCP and industry omnichannel engagement trends in life sc...Across Health
Ruud Kooi (MD Across Health) and Luisa Schirm (VP Global Accounts) share highlights from our latest Global Trends Report, including some of last year's most interesting insights pulled from our industry-leading Navigator365™ and Maturometer™ research. You can look forward to a unique snapshot of what biopharma and its HCP audiences have been thinking and doing in the omnichannel space in 2023, as well as a look ahead at what to expect in 2024 and beyond.
Key topics discussed:
- Enduring shifts in HCP channel & content affinity & impact
- HCP interest in & (dis)satisfaction with biopharma’s digital offerings
- The competitive landscape
- Insights and key regional trends for EU5, US & APAC
Watch the recorded webinar and access the full deck here:
http://tinyurl.com/yptwadcm
Across Health - Global HCP & competitor omnichannel trends in life sciences 2...Across Health
Fonny Schenck (Strategic Management Advisor) and Patrick Vidal (SVP Global Accounts) shared highlights from our 2022 Global Trends Report, including some of last year's most interesting insights pulled from our industry-leading Navigator365™ and Maturometer™ research. You can look forward to a unique snapshot of what biopharma and its HCP and payer audiences have been thinking and doing in the omnichannel space in 2022, as well as a look ahead at what to expect in 2023 and beyond.
Key topics included:
• Enduring shifts in HCP channel & content affinity & impact
• HCP interest in & (dis)satisfaction with biopharma’s digital offerings
• The competitive landscape
• Future scenarios
• Insights and key trends for EU5, US, LATAM & APAC
Watch the recorded webinar and access the full deck here: https://rb.gy/h1qu5x
Across Health - 'Omnichannel myopia' in the post-Covid era- The importance of...Across Health
Beverly Smet (VP Global Accounts) and Vanessa Huichard (Senior Strategy Consultant) advised on how to benchmark your brand for omnichannel leadership and how robust benchmarking can support you in sound business planning.
Key topics included:
• “Marketing myopia” – what’s in a name
• How the pandemic disrupted the landscape for Cx and OC effectiveness
• Creating a burning platform for Cx by adopting an outside-in perspective
• How robust benchmarking can support sound business planning: case example
Watch the recorded webinar and access the full deck here: https://rb.gy/guxkhq
Across Health - Navigator365™ product updates and plans for 2023Across Health
Pim ten Tusscher (CTO- Across Health) and Christophe Brock (Head of Impact – Across Health) gave a 40-minute update on the latest product developments, as well as a preview of our exciting plans for 2023!
Key topics included:
• Two new products: Navigator365™ Benchmark & Navigator365™ Payer
• A fully redesigned Navigator365™ Planner allowing you to plan and quantify your omnichannel plans
• A new iteration of Navigator365™ Core with a dedicated omnichannel launch section
• Two additions to our Omnitopia™ serious game offering: Field-Commercial and Medical
• A fully revised Missing Manual – the handbook for omnichannel excellence in the life sciences
• A sneak peek of our 2023 plans!
Watch the recorded webinar and access the full deck here: https://bit.ly/3BDnAew
Across Health - Omnichannel for Payers: A big opportunity for pharma Across Health
During our recent live webinar, David Ziedman (SVP Global Accounts) and Jason Cunningham (Senior Consultant) explored how omnichannel offers an untapped opportunity for pharma to connect with Payers more effectively.
Key topics included:
• Achieving the most impactful channel mix for this target group
• How does pharma’s digital offering compare to what Payers actually want?
• Channels used by Payers with the highest reach, impact and frequency (with insights from the recently launched Navigator365™ Payer)
• How benchmarking can tell us which companies are performing well (and not so well) in Omnichannel
Watch the recorded webinar and access the full deck here: http://bit.ly/3VpujQH
Across Health - Omnichannel Launch Excellence: Medical & Commercial best prac...Across Health
During last year’s webinar on the same topic we discussed our perspectives on post-C19 launch excellence, and we all agreed that the New Normal will never be the same. During this year’s webinar on Omnichannel Launch Excellence, Ruud Kooi (SVP Global Accounts) and Ben Harbour (Senior Consultant) discussed on how to optimize your omnichannel launch and discover solutions to some of the potential obstacles you might face.
Key topics included:
• How to create an evidence-based roadmap for Medical and Commercial omnichannel launch – at the international and local level
• 5 tips to optimize your Medical and Commercial omnichannel launch
• Case study: Preparing for a Medical and Commercial launch – challenges and solutions
Watch the recorded webinar and access the full deck here: http://bit.ly/3u0lcdz
Is biopharma ready for the New Normal and how far have we progressed along the path to omnichannel maturity? Fonny Schenck (MD Across Health, EVP Precision Value & Health) & Sander Geysen (Senior Consultant) will share the highlights of the 2022 Maturometer™ survey, giving you a unique overview of the current state of digital transformation within life science companies.
Key topics included:
(Digital) transformation: just “talking the talk”? Or well underway?
Key investment focus: channels, technologies, data, content, capabilities,…
Digital share of the go-to-market budget mix
Key barriers & drivers
Key priorities for continued success in the age of omnichannel excellence
Watch the recorded webinar and access the full deck here: https://bit.ly/3CjnQyZ
Post-COVID Omnichannel HCP engagement Romania – key trends.pdfAcross Health
In this webinar, Beverly Smet (SVP Global Accounts) and Pieterjan Dhondt (Associate Consultant) elaborated on some of the key trends in the Romanian specialty landscape, gathered from our Navigator365™ HCP Omnichannel affinity research.
Key topics included:
- How do Romanian HCPs compare to their EU5 colleagues?
- How did COVID19 affect the reach & impact of your promotional & medical channels?
- How satisfied are Romanian HCPs with pharma’s current digital offering?
Find out more here: https://bit.ly/3yUnFsm
Tips for your 2023 omnichannel budget planning.pdfAcross Health
Vladimir Rogiers (Senior Consultant) and Jan Keuppens (SVP Global Accounts) discovered how omnichannel thinking should be a key dimension of your 2023 business planning, as well as addressing key business questions and offering some essential tips and evidence.
Key topics included:
• Which channels, media and content do my customers prefer? And where does my brand do well (and not so well) versus the competition?
• How do I translate my strategic imperatives, leverage points and key segments into pragmatic customer journeys?
• What kind of budget should I set aside for this? What % should go to digital?
• What kind of business impact can I expect from my omnichannel plan? And how do I prepare for execution excellence?
Watch the recorded webinar and access the full deck here: https://bit.ly/3NH8nw8
Omnichannel launch excellence in the never normalAcross Health
Like many other things, launch excellence will never be the same again post-C19… Ruud Kooi (SVP Global Accounts) and Luisa Schirm (Senior Consultant) will show you how an integrated customer-centric approach should be an essential ingredient of any launch – now, more than ever.
Key topics include:
· Omnichannel as the “booster shot” for post-C19 launches
· The Omnichannel Launch Excellence (O.L.E.) framework explained
· How to translate a global/regional customer-centric O.L.E blueprint into local strategy execution success?
Watch the recorded webinar and access the full deck here: https://bit.ly/3xOkuBs
Kyle Patel (Senior Consultant) and Luisa Schirm (Senior Consultant) will illustrate how to translate your strategic imperatives into a high-impact customer engagement strategy with our Navigator365™ and Scala365™ product suites.
Key topics included:
• How to facilitate the planning and impact measurement phase in the New Normal era with Navigator365™ and Scala365™
• What are some of the key components in boosting your omnichannel capabilities and staying ahead with the ultimate OCE guide?
• How to operate in the post-C19 world with our cloud based OCE product suite
Watch the recorded webinar and access the full deck here: https://bit.ly/3EFsqqJ
Across Health SVP Global Accounts Beverly Smet and Jan Keuppens will demonstrate the latest insights from our Navigator365™ omnichannel affinity research, emphasizing more the significance of a true transformation within pharma organizations in the New Normal era.
Key topics included:
• The impact of covid in the traditional business model, sales & marketing collaboration levels, and the key pharma channels
• What are some of the ingredients required to create a seamless customer experience and how to drive omnichannel customer engagement in the Next Normal?
• How to pump up the digital volume by building an integrated marketing & sales engine for B2B
Watch the recorded webinar and access the full deck here: https://bit.ly/3GFUaNX
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Telehealth Psychology Building Trust with Clients.pptxThe Harvest Clinic
Telehealth psychology is a digital approach that offers psychological services and mental health care to clients remotely, using technologies like video conferencing, phone calls, text messaging, and mobile apps for communication.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.